234 related articles for article (PubMed ID: 27866948)
1. Pulmonary Embolism Rates Following Total Hip Arthroplasty With Prophylactic Anticoagulation: Some Pulmonary Emboli Cannot Be Avoided.
Lieberman JR; Cheng V; Cote MP
J Arthroplasty; 2017 Mar; 32(3):980-986. PubMed ID: 27866948
[TBL] [Abstract][Full Text] [Related]
2. Persistent Pulmonary Embolism Rates Following Total Knee Arthroplasty Even With Prophylactic Anticoagulants.
Cote MP; Chen A; Jiang Y; Cheng V; Lieberman JR
J Arthroplasty; 2017 Dec; 32(12):3833-3839. PubMed ID: 28807470
[TBL] [Abstract][Full Text] [Related]
3. Factor Xa Inhibitors and Direct Thrombin Inhibitors Versus Low-Molecular-Weight Heparin for Thromboprophylaxis After Total Hip or Total Knee Arthroplasty: A Systematic Review and Meta-Analysis.
Sun G; Wu J; Wang Q; Liang Q; Jia J; Cheng K; Sun G; Wang Z
J Arthroplasty; 2019 Apr; 34(4):789-800.e6. PubMed ID: 30685261
[TBL] [Abstract][Full Text] [Related]
4. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty.
Freedman KB; Brookenthal KR; Fitzgerald RH; Williams S; Lonner JH
J Bone Joint Surg Am; 2000 Jul; 82-A(7):929-38. PubMed ID: 10901307
[TBL] [Abstract][Full Text] [Related]
5. Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis.
Lu X; Lin J
BMC Musculoskelet Disord; 2018 Sep; 19(1):322. PubMed ID: 30193575
[TBL] [Abstract][Full Text] [Related]
6. Oral direct Factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and meta-analysis.
Neumann I; Rada G; Claro JC; Carrasco-Labra A; Thorlund K; Akl EA; Bates SM; Guyatt GH
Ann Intern Med; 2012 May; 156(10):710-9. PubMed ID: 22412038
[TBL] [Abstract][Full Text] [Related]
7. Venous thromboprophylaxis after total hip arthroplasty: aspirin, warfarin, enoxaparin, or factor Xa inhibitors?
Bala A; Murasko MJ; Burk DR; Huddleston JI; Goodman SB; Maloney WJ; Amanatullah DF
Hip Int; 2020 Sep; 30(5):564-571. PubMed ID: 30990095
[TBL] [Abstract][Full Text] [Related]
8. Aspirin for Venous Thromboembolic Prophylaxis Following Total Hip and Total Knee Arthroplasty: An Analysis of Safety and Efficacy Accounting for Surgeon Selection Bias.
Heckmann ND; Piple AS; Wang JC; Richardson MK; Mayfield CK; Oakes DA; Christ AB; Lieberman JR
J Arthroplasty; 2023 Jul; 38(7 Suppl 2):S412-S419.e1. PubMed ID: 36870517
[TBL] [Abstract][Full Text] [Related]
9. Symptomatic in-hospital deep vein thrombosis and pulmonary embolism following hip and knee arthroplasty among patients receiving recommended prophylaxis: a systematic review.
Januel JM; Chen G; Ruffieux C; Quan H; Douketis JD; Crowther MA; Colin C; Ghali WA; Burnand B;
JAMA; 2012 Jan; 307(3):294-303. PubMed ID: 22253396
[TBL] [Abstract][Full Text] [Related]
10. A prospective comparison of warfarin to aspirin for thromboprophylaxis in total hip and total knee arthroplasty.
Intermountain Joint Replacement Center Writing Committee
J Arthroplasty; 2012 Jan; 27(1):1-9.e2. PubMed ID: 21621959
[TBL] [Abstract][Full Text] [Related]
11. Potent Anticoagulation Does Not Reduce Venous Thromboembolism in High-Risk Patients.
Tan TL; Foltz C; Huang R; Chen AF; Higuera C; Siqueira M; Hansen EN; Sing DC; Parvizi J
J Bone Joint Surg Am; 2019 Apr; 101(7):589-599. PubMed ID: 30946192
[TBL] [Abstract][Full Text] [Related]
12. Fatal pulmonary embolism following elective total hip arthroplasty: a 12-year study.
Bayley E; Brown S; Bhamber NS; Howard PW
Bone Joint J; 2016 May; 98-B(5):585-8. PubMed ID: 27143726
[TBL] [Abstract][Full Text] [Related]
13. Time to Venous Thromboembolism Events Following Total Hip Arthroplasty: A Comparison Between Aspirin and Warfarin.
Shohat N; Goel R; Ludwick L; Parvizi J
J Arthroplasty; 2022 Jun; 37(6):1198-1202.e1. PubMed ID: 35149168
[TBL] [Abstract][Full Text] [Related]
14. DVT prophylaxis: better living through chemistry: affirms.
Pellegrini VD
Orthopedics; 2010 Sep; 33(9):642. PubMed ID: 20839678
[TBL] [Abstract][Full Text] [Related]
15. Comparative Effectiveness and Safety of Drug Prophylaxis for Prevention of Venous Thromboembolism After Total Knee Arthroplasty.
Cafri G; Paxton EW; Chen Y; Cheetham CT; Gould MK; Sluggett J; Bini SA; Khatod M
J Arthroplasty; 2017 Nov; 32(11):3524-3528.e1. PubMed ID: 28634095
[TBL] [Abstract][Full Text] [Related]
16. Are bilateral total joint arthroplasty patients at a higher risk of developing pulmonary embolism following total hip and knee surgery?
Yeager AM; Ruel AV; Westrich GH
J Arthroplasty; 2014 May; 29(5):900-2. PubMed ID: 24360492
[TBL] [Abstract][Full Text] [Related]
17. Multimodal prophylaxis in patients with a history of venous thromboembolism undergoing primary elective hip arthroplasty.
Gonzalez Della Valle A; Shanaghan KA; Nguyen J; Liu J; Memtsoudis S; Sharrock NE; Salvati EA
Bone Joint J; 2020 Jul; 102-B(7_Supple_B):71-77. PubMed ID: 32600195
[TBL] [Abstract][Full Text] [Related]
18. Comparison of 90-Day Adverse Events Associated With Aspirin and Potent Anticoagulation Use for Venous Thromboembolism Prophylaxis: A Cohort Study of 72,288 Total Knee and 35,142 Total Hip Arthroplasty Patients.
Singh G; Prentice HA; Winston BA; Kroger EW
J Arthroplasty; 2023 Aug; 38(8):1602-1612.e1. PubMed ID: 36805118
[TBL] [Abstract][Full Text] [Related]
19. A Phase IV Study of Thromboembolic and Bleeding Events Following Hip and Knee Arthroplasty Using Oral Factor Xa Inhibitor.
Gomez D; Razmjou H; Donovan A; Bansal VB; Gollish JD; Murnaghan JJ
J Arthroplasty; 2017 Mar; 32(3):958-964. PubMed ID: 27843040
[TBL] [Abstract][Full Text] [Related]
20. Comparative effectiveness of new oral anticoagulants and standard thromboprophylaxis in patients having total hip or knee replacement: a systematic review.
Adam SS; McDuffie JR; Lachiewicz PF; Ortel TL; Williams JW
Ann Intern Med; 2013 Aug; 159(4):275-84. PubMed ID: 24026260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
